Stocks to buy this week: L&T, Exide, Aurobindo Pharma, BHEL among 12 technical picks; do you own any?
Nifty 50 gained 2 per cent in September, but the short-term outlook remains hazy due to concerns over rate hikes and foreign capital outflow. Mixed cues for October.
Benchmark Nifty 50 ended with a gain of 2 per cent last month amid prevailing headwinds, including concerns over rate hikes, foreign capital outflow, sharp gains in the US Treasury yields, dollar and crude oil prices.
Get the best recommendations on Stocks, Mutual Funds and more based on your Risk profile!Let’s get started